alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
​
​

Exhibit 10.1
March 11, 2020
​
​
ELEVENTH AMENDMENT TO PROMISSORY NOTE
​
​
This Eleventh Amendment to Promissory Note (this “Amendment”) is to be effective as of the close of business March 11, 2020, or as otherwise stated herein.
​
WHEREAS, the undersigned are parties to that certain Promissory Note (as the same has been and may be hereafter renewed, amended, modified, or extended, the “Note”) dated as of March 12, 2009 in the original amount of $12,910,386.14, made by WEINGARTEN REALTY INVESTORS (“Weingarten”), a Texas real estate investment trust, and payable to the order of RELIANCE TRUST COMPANY, the directed non-discretionary trustee (“Trustee”) of the Master Nonqualified Plan Trust (the “Trust”) under the Weingarten Realty Investors Supplemental Executive Retirement Plan and Weingarten Realty Investors Retirement Benefit Restoration Plan (collectively the “Plans”); and
​
WHEREAS, the scheduled maturity date of the Note is March 12, 2020; and 
​
WHEREAS, Weingarten and the Plans desire to extend the maturity date under the Note to a date one year from the date of its currently-scheduled maturity; and 
​
WHEREAS, Weingarten and the Plans desire to amend the Note to reflect this change and desire to memorialize the outstanding balance due under the Note as of March 11, 2020;
​
NOW, THEREFORE, it is agreed:
​
	1.
	The second paragraph of the Note shall be revised to be and read as follows:


​
“The entire unpaid balance of the Note, including accrued interest, shall be due and payable March 12, 2021.” 
​
	2.
	As of the close of business March 11, 2020, the balance due under the Note, including accrued interest, is $893,287.47.


​
In all other respects, the Note is hereby ratified and confirmed. 
​
This instrument may be executed by the parties individually or in combination, in one or more counterparts, each of which shall be an original and all of which shall together constitute one and the same instrument. Individuals authorized to enter into this amendment on behalf of Weingarten are identified on Exhibit A hereto.
​
​

Eleventh Amendment to Promissory Note - 1
​




​
​

	​


	​


	​



	​
	RELIANCE TRUST COMPANY, as Trustee of the Trust 

	​
	​

	​
	​

	​
	By:
	/s/ Kimberly Lowe

	​
	​
	​

	​
	Its (Title):
	Senior Vice President

	​
	​
	​

	​
	Date:
	February 18, 2020

	​
	​
	​

	​
	​
	​

	​
	​
	​

	​
	WEINGARTEN REALTY INVESTORS

	​
	​

	​
	Stephen Richter

	​
	Executive Vice President, CFO

	​
	February 11, 2020

	​
	​

	​
	By:
	/s/ Steve Richter



​
​
​
​

Eleventh Amendment to Promissory Note - 2
​




​
​

Exhibit A
​
Individuals Authorized to Enter into the Eleventh Amendment to Promissory Note 
on behalf of Weingarten
​
​
Andrew M. Alexander
Stephen C. Richter

Eleventh Amendment to Promissory Note - 3
​
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 96-592

In Re: JOHN J. BUCKSHAW, Petitioner.

On Petition for Writ of Mandamus. (CA-96-30-3-MC) Submitted: January 14, 1997 Decided: January 24, 1997 Before MURNAGHAN, NIEMEYER, and HAMILTON, Circuit Judges. Petition denied by unpublished per curiam opinion. John J. Buckshaw, Petitioner Pro Se. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM:John J. Buckshaw filed a petition for a writ of mandamus seeking an order compelling the district court to conduct an evidentiary hearing and an injunction. We deny the petition. Mandamus is a drastic remedy to be used only in extraordinary circumstances. Kerr v. United States Dist. Court , 426 U.S. 394, 402 (1976). Mandamus relief is only available when there are no other means by which the relief sought could be granted, In re Beard , 811 F.2d 818, 826 (4th Cir. 1987), and may not be used as a substitute for appeal. In re United Steelworkers , 595 F.2d 958, 960 (4th Cir. 1979). The party seeking mandamus relief carries the heavy burdenof showing that he has "no other adequate means to attain the relief he desires" and that his right to such relief is "clear and indisputable." Allied Chem. Corp. v. Daiflon, Inc. , 449 U.S. 33, 35 (1980). Buckshaw has not made such a showing. Accordingly, we deny his petition for a writ of mandamus. Buckshaw is granted leave to proceed in forma pauperis. We dispense with oral argument becausethe facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

PETITION DENIED
<PAGE>   1


                                                                      Exhibit 11

            Healthdyne Information Enterprises, Inc. and Subsidiaries
             Statements of Computation of Per Share Earnings (Loss)
                    (in thousands, except per share amounts)

<TABLE>
<CAPTION>
                                                      THREE MONTHS ENDED MARCH 31,
                                                        1997              1996
                                                              (UNAUDITED)

<S>                                                   <C>               <C>   
Net earnings (loss)                                   $  (503)          $   110
                                                   ==================================

Primary shares:
     Weighted average number of common shares
     outstanding                                       20,182            16,593

     Additional shares issuable from assumed
     exercise of options (see note 1)                       0             1,524
                                                   ==================================
                                                       20,182            18,117
                                                   ==================================

Earnings (loss) per common share and common
share equivalent                                      $ (0.02)          $  0.01
                                                   ==================================

Fully diluted shares:
     Weighted average number of common shares
     outstanding                                       20,182            16,593

     Additional shares issuable from assumed
     exercise of options (see note 1)                       0             1,787
                                                   ----------------------------------
                                                       20,182            18,380
                                                   ==================================

Earnings (loss) per common share and common
share equivalent                                      $ (0.02)          $  0.01
                                                   ==================================
</TABLE>

Note 1:     Since stock options are anti-dilutive to the loss per common
            share calculations, stock options are not considered in such loss
            per share calculations for the three months ended March 31, 1997.
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1727 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 1727

    To amend title XVIII of the Social Security Act to provide for 
  coverage, as supplies associated with the injection of insulin, of 
 containment, removal, decontamination and disposal of home-generated 
    needles, syringes, and other sharps through a sharps container, 
   decontamination/destruction device, or sharps-by-mail program or 
         similar program under part D of the Medicare program.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 26, 2015

 Mr. Whitfield (for himself and Ms. DeGette) introduced the following 
 bill; which was referred to the Committee on Energy and Commerce, and 
  in addition to the Committee on Ways and Means, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL

 
    To amend title XVIII of the Social Security Act to provide for 
  coverage, as supplies associated with the injection of insulin, of 
 containment, removal, decontamination and disposal of home-generated 
    needles, syringes, and other sharps through a sharps container, 
   decontamination/destruction device, or sharps-by-mail program or 
         similar program under part D of the Medicare program.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Medicare Safe Needle Disposal 
Coverage Act of 2015''.

SEC. 2. COVERAGE OF CONTAINMENT, REMOVAL, DECONTAMINATION AND DISPOSAL 
              OF HOME-GENERATED NEEDLES, SYRINGES, AND OTHER SHARPS 
              THROUGH A SHARPS CONTAINER, DECONTAMINATION/DESTRUCTION 
              DEVICE, OR SHARPS-BY-MAIL PROGRAM OR SIMILAR PROGRAM 
              UNDER MEDICARE PART D.

    (a) In General.--Section 1860D-2(e)(1)(B) of the Social Security 
Act (42 U.S.C. 1395w-102(e)(1)(B)) is amended by inserting after 
``regulations of the Secretary'' the following: ``and including devices 
approved for home use by the Food and Drug Administration for the safe 
and effective containment, removal, decontamination and disposal of 
home-generated needles, syringes, and other sharps through a sharps 
container, decontamination/destruction device, or sharps-by-mail 
program or similar program''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
take effect on the date that is one year after the date of the 
enactment of this Act.
                                 <all>
```
11 TH COURT OF APPEALS EASTLAND , TEXAS JUDGMENT
Patrick Shawn Elizondo , * From the 244 th District Court
o f Ector County, Trial Court No s

. C

- 20

- 0630

- CR, C

- 20

- 0631

- CR, & C

- 20

- 0729

- CR

Vs. No. 11

- 21

- 00 173

- CR * February 23 , 2023

The State of Texas , * Memorandum Opinion by Williams , J

. (P anel consists of: Bailey , C.J., Trotter, J., and Williams, J. ) This court has inspected the record in this cause and concludes that there is no error in the judgment below. Therefore, in accordance with this court ’ s opi nion, the judgment of the trial court is in all things affirmed.
<PAGE>

===============================================================================


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C.  20549

                          ----------------------------

                                   FORM 10-QSB

(Mark One)
  [X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
        EXCHANGE ACT OF 1934

                 For the quarterly period ended March 31, 2001

                                      -OR-

  [_]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
        EXCHANGE ACT OF 1934

                     For the transition period from...to...

                          Commission File No. 333-36379



                            PACIFICHEALTH LABORATORIES, INC.
               (Exact name of issuer as specified in its charter)


           DELAWARE                                      22-3367588
     (State or other jurisdiction of                  (I.R.S. Employer
     incorporation or organization)                 Identification Number)

       1480 Route 9 North, Suite 204
             Woodbridge, NJ                                07095
 (Address of principal executive offices)                (Zip Code)


      Registrant's telephone number, including area code:  (732) 636-6141

Check whether the issuer (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past
90 days. Yes [X] No [_]

At May 10, 2001, there were 5,121,367 shares of common stock, par value $.0025
per share, of the registrant outstanding.

Transitional small business disclosure format: Yes  [ ] No [X]


<PAGE>



                                   SIGNATURES


          Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.


                                      PACIFICHEALTH LABORATORIES, INC.


                                      By: /S/ STEPHEN P. KUCHEN
                                          ------------------------------
                                          STEPHEN P. KUCHEN

                                      Vice President - Finance & CFO
                                      (Principal Financial Officer and
                                      Principal Accounting Officer)

                                      Date: MAY 21, 2001
                                            ----------------------------
U.S. District Court – Oregon Application for Special Admission – Pro Hac Vice

[Rev. 11/2018] Page 1 of 4 

UNITED STATES DISTRICT COURT 

DISTRICT OF OREGON 

Case No.: ________________________

 Plaintiff(s),

v.

APPLICATION FOR SPECIAL 

ADMISSION – PRO HAC VICE

Defendant(s). 

Application for Pro Hac Vice Admission and CM/ECF Registration 

Attorney _________________________________ requests special admission pro hac 

vice to the Bar of the United States District Court for the District of Oregon in the abovecaptioned case for the purposes of representing the following party(s): 

______________________________________________________________________________ 

In support of this application, I certify that: 1) I am an active member in good standing 

with the _____________ State Bar; and 2) that I have read and am familiar with the Federal 

Rules of Evidence, the Federal Rules of Civil and Criminal Procedure, the Local Rules of this 

Court, and this Court's Statement of Professionalism. 

I understand that my admission to the Bar of the United States District Court for the 

District of Oregon is solely for the purpose of litigating in the above matter and will be 

terminated upon the conclusion of the matter. 

(1) PERSONAL DATA:

Name:

(Last Name) (First Name) (MI) (Suffix)

Agency/firm affiliation: 

Mailing address: 

City: State:___________ Zip: 

Phone number: Fax number: 

Business e-mail address: 

15-cv-01857-SI Jay Edelson Plaintiff, Lori Wakefield Illinois Edelson Jay Edelson PC 350 North LaSalle St, 14th Floor Chicago IL 60654 (312) 589-6370 (312) 589-6378 jedelson@edelson.com Lori Wakefield Visalus, Inc.

Case 3:15-cv-01857-SI Document 348 Filed 10/02/19 Page 1 of 4
Case 3:15-cv-01857-SI Document 348 Filed 10/02/19 Page 2 of 4
10/02/2019

s/Scott Kocher

Case 3:15-cv-01857-SI Document 348 Filed 10/02/19 Page 3 of 4
U.S. District Court – Oregon Application for Special Admission – Pro Hac Vice

[Rev. 11/2018] Page 4 of 4 

COURT ACTION 

Application for pro hac vice admission by _________________________ in case number: 

___________________ is hereby: 

 Approved subject to payment of fees.

 Denied.

DATED: ________________________________. 

_______________________________________ 

Judge 

15-cv-01857-SI Jay Edelson

Case 3:15-cv-01857-SI Document 348 Filed 10/02/19 Page 4 of 4
[Federal Register Volume 86, Number 160 (Monday, August 23, 2021)]
[Notices]
[Pages 47151-47152]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18020]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--MLCommons Association

    Notice is hereby given that on July 12, 2021, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. Section 4301 et seq. (the ``Act''), MLCommons Association 
(``MLCommons'') filed written notifications simultaneously with the

[[Page 47152]]

Attorney General and the Federal Trade Commission disclosing changes in 
its membership. The notifications were filed for the purpose of 
extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, Sanjay Purushotham (individual member), Baltimore, MD; 
Rebellions Inc., Gyeonggi-do, REPUBLIC OF KOREA; Nutanix, San Jose, CA; 
Huawei Technologies Co., Ltd. (ELO), Shenzhen, PEOPLE'S REPUBLIC OF 
CHINA; Sam Ade Jacobs (individual member), Livermore, CA; Nel Swanepoel 
(individual member), London, UNITED KINGDOM; and Ayoub Elhanchi 
(individual member), Brossard, CANADA have joined as parties to this 
venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open and MLCommons intends to file additional 
written notifications disclosing all changes in membership.
    On September 15, 2020, MLCommons filed its original notification 
pursuant to Section 6(a) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to Section 6(b) of 
the Act on September 29, 2020 (85 FR 61032).
    The last notification was filed with the Department on April 28, 
2021. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on May 25, 2021 (86 FR 28148).

Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2021-18020 Filed 8-20-21; 8:45 am]
BILLING CODE 4410-11-P
Exhibit 31.2

Section 302 CFO Certification

I, Robert F. Apple, certify that:

1. I have reviewed this annual report on Form 10-K of Antares Pharma, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this report;

4. The registrants other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and

c) Disclosed in this report any change in the registrants
internal control over financial reporting that occurred during the registrants most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial
reporting; and

5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

b) Any fraud,
whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.

Date: May 4, 2006



|                                                 
|-------------------------------------------------
|/s/ ROBERT F. APPLE                              
|Robert F. Apple                                  
|Senior Vice President and Chief Financial Officer
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 98-2250

MORRIS RIDDLE, Plaintiff - Appellant, versus ABF FREIGHT SYSTEM, INCORPORATED, Defendant - Appellee. Appeal from the United States District Court for the Western District of North Carolina, at Charlotte. Graham C. Mullen, Chief District Judge. (CA-96-537-3-MU) Submitted: December 17, 1998 Decided: December 29, 1998 Before WILKINS, NIEMEYER, and TRAXLER, Circuit Judges. Affirmed by unpublished per curiam opinion. Morris Riddle, Appellant Pro Se. Louis Adams Bledsoe, III, Douglas Marshall Jarrell, ROBINSON, BRADSHAW & HINSON, P.A., Charlotte, North Carolina, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM:Morris Riddle appeals the district court’s order granting Defendant’s motion for summary judgment and dismissing his complaint in which he asserted that he was terminated in violation of the Americans with Disabilities Act of 1990, 42 U.S.C.A. §§ 12101-12213(West 1995 & Supp. 1998). We have reviewed the record and the district court’s opinion and find no reversible error. Accordingly, we affirm on the reasoning of the district court. See Riddle v. ABF Freight Sys., Inc. , No. CA-96-537-3-MU (W.D.N.C. July 16, 1998). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Cropping Systems Research Laboratory: Lubbock, TX
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                                    Software
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us






CSRL AgSciences Seminar Series (1)headline bar 2019 AgSciences Seminar Series
               2020 AgSciences Seminar Series


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov